Reference · cited facts
AOD-9604
Half-life No established human half-lifeResearch use · not FDA-approvedReviewed July 2026
Educational information and a math tool only — not medical advice, a dose recommendation, or an endorsement of peptide use. Not FDA-approved for human use. Consult a licensed healthcare provider before starting, stopping, or changing anything.
Class / mechanism
AOD-9604 is a fragment of human growth hormone (residues 176–191).
SOURCE [1]
Regulatory status
Not FDA-approved. Removed from the FDA 503A Category-2 bulk list (Sep 2024); WADA-listed. Status in flux pending the July 2026 PCAC review.
FDA · July 2026
Reported half-life
No established human half-life
NO RELIABLE HUMAN SOURCE
Human evidence
Limited (largely negative human trials)
LITERATURE
What the literature reports
- AOD-9604 is a fragment of human growth hormone (residues 176–191).
- Human Phase 2 fat-loss trials did not confirm a weight-loss benefit.
- No firmly established human half-life value exists in the peer-reviewed literature.
Honest caveats
- • Human trials largely did not show the outcomes it is marketed for.
- • Regulatory status changed in 2024–2026 and is under review — treat any status as dated.
Reconstitution calculator
Enter your own vial size, BAC water and target dose — get exact syringe units.
Sources